Article
Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.
Molecular Cardiology and Angiogenesis Laboratory, Department of Surgery, University of Connecticut School of Medicine, 263 Farmington Ave., Farmington, CT 06032-1110, USA.
Antioxidants & Redox Signaling (impact factor:
8.2).
11/2010;
15(7):1789-97.
DOI:10.1089/ars.2010.3769
pp.1789-97
Source: PubMed
-
Citations (0)
-
Cited In (0)
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
Bcl-2 signaling pathway
Decreased infarct size
DNA binding activity
endothelial nitric oxide synthase
global ischemia
HIF-1α-mediated cardioprotection
HIF-1α/β-catenin/endothelial nitric oxide synthase/nuclear factor-kappaB
Hypoxia-inducible transcription factor
mRNA expression
myocardial infarction
oxygen-dependent manner
peripheral artery occlusive disease
PHD enzymes
PHD-1 attenuates myocardial I/R injury
PHD1TMC
potential treatment option
wild-type ischemia/reperfusion
WT I/R
WT time-matched control
WTIR